V280G Mutation, Potential Role in Imatinib Resistance: First Case Report

Article English OPEN
Azevedo, Ana P; Reichert, Alice; Afonso, Celina; Alberca, Maria D; Tavares, Purificação; Lima, Fernando;
(2017)
  • Publisher: SAGE Publishing
  • Journal: Clinical Medicine Insights: Oncology,volume 11 (issn: 1179-5549, eissn: 1179-5549)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.1177/1179554917702870, pmc: PMC5395261
  • Subject: BCR-ABL | CML | case report | Hasford score | Neoplasms. Tumors. Oncology. Including cancer and carcinogens | BCR ABL protein | clinical article | glycine | nilotinib | chronic myeloid leukemia | drug dose escalation | female | human | leukoderma | EUTOS score | alpha interferon | disease course | gene | gene mutation | gene sequence | aged | imatinib | Sokal score | chromosome 9 | Article | Mutation | BCR ABL gene | hydroxyurea | RC254-282 | reverse transcription polymerase chain reaction | chromosome 22 | valine | amino acid substitution | drug withdrawal | splenomegaly
    mesheuropmc: hemic and lymphatic diseases

Export Date: 28 December 2017 Correspondence Address: Azevedo, A.P.; Department of Clinical Pathology, Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Estrada do Forte do Alto do Duque, Portugal; email: anpazevedo@gmail.com Chemicals/CAS: glycine, 56-... View more
Share - Bookmark